MiNK Therapeutics

MiNK Therapeutics

  • Founded: 2017
  • Location: Lexington, MA
  • Employee range: 11 - 50
  • Clinical stage: Clin1
  • Therapy area: Multiple myeloma
  • Drug types: ONC, LNG, INF, IMM
  • Lead product: Agent -797
  • Product link: https://minktherapeutics.com/
  • Funding: $40M IPO Oct 2021



job board

Short description:

Cell Therapy, CAR-T

Drug notes:

Also Clin1 solid tumors, Clin1 viral infection ARDS; MiNK-215 Clin0 oncology; MiNK-413 Clin0 oncology; 2 undisclosed programs RD/Clin0 oncology

Long description:

Contact us to add description.


© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com